PortalPublikationenCost-of-illness of patients with chronic hand eczema in rout...

Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany.

Standard

Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany. / Augustin, Matthias; Kuessner, D; Purwins, Sandra; Hieke, K; Posthumus, J; Diepgen, T L.

in: BRIT J DERMATOL, Jahrgang 165, Nr. 4, 4, 2011, S. 845-851.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Augustin, M, Kuessner, D, Purwins, S, Hieke, K, Posthumus, J & Diepgen, TL 2011, 'Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany.', BRIT J DERMATOL, Jg. 165, Nr. 4, 4, S. 845-851. <http://www.ncbi.nlm.nih.gov/pubmed/21623744?dopt=Citation>

APA

Augustin, M., Kuessner, D., Purwins, S., Hieke, K., Posthumus, J., & Diepgen, T. L. (2011). Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany. BRIT J DERMATOL, 165(4), 845-851. [4]. http://www.ncbi.nlm.nih.gov/pubmed/21623744?dopt=Citation

Vancouver

Augustin M, Kuessner D, Purwins S, Hieke K, Posthumus J, Diepgen TL. Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany. BRIT J DERMATOL. 2011;165(4):845-851. 4.

Bibtex

@article{417ef01c89174f53bf8fff5dd025a3d3,
title = "Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany.",
abstract = "It is broadly assumed that costs caused by chronic hand eczema (CHE) are significant. However, there is a lack of cost-of-illness studies on CHE.",
keywords = "Germany, Humans, Male, Female, Middle Aged, Cost-Benefit Analysis, Cost of Illness, Treatment Outcome, Cross-Sectional Studies, Chronic Disease, Dermatologic Agents/economics/therapeutic use, Drug Costs, Eczema/*economics/therapy, Hand Dermatoses/*economics/therapy, Hospitalization/economics, Ultraviolet Therapy/economics, Germany, Humans, Male, Female, Middle Aged, Cost-Benefit Analysis, Cost of Illness, Treatment Outcome, Cross-Sectional Studies, Chronic Disease, Dermatologic Agents/economics/therapeutic use, Drug Costs, Eczema/*economics/therapy, Hand Dermatoses/*economics/therapy, Hospitalization/economics, Ultraviolet Therapy/economics",
author = "Matthias Augustin and D Kuessner and Sandra Purwins and K Hieke and J Posthumus and Diepgen, {T L}",
year = "2011",
language = "English",
volume = "165",
pages = "845--851",
journal = "BRIT J DERMATOL",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS

TY - JOUR

T1 - Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany.

AU - Augustin, Matthias

AU - Kuessner, D

AU - Purwins, Sandra

AU - Hieke, K

AU - Posthumus, J

AU - Diepgen, T L

PY - 2011

Y1 - 2011

N2 - It is broadly assumed that costs caused by chronic hand eczema (CHE) are significant. However, there is a lack of cost-of-illness studies on CHE.

AB - It is broadly assumed that costs caused by chronic hand eczema (CHE) are significant. However, there is a lack of cost-of-illness studies on CHE.

KW - Germany

KW - Humans

KW - Male

KW - Female

KW - Middle Aged

KW - Cost-Benefit Analysis

KW - Cost of Illness

KW - Treatment Outcome

KW - Cross-Sectional Studies

KW - Chronic Disease

KW - Dermatologic Agents/economics/therapeutic use

KW - Drug Costs

KW - Eczema/economics/therapy

KW - Hand Dermatoses/economics/therapy

KW - Hospitalization/economics

KW - Ultraviolet Therapy/economics

KW - Germany

KW - Humans

KW - Male

KW - Female

KW - Middle Aged

KW - Cost-Benefit Analysis

KW - Cost of Illness

KW - Treatment Outcome

KW - Cross-Sectional Studies

KW - Chronic Disease

KW - Dermatologic Agents/economics/therapeutic use

KW - Drug Costs

KW - Eczema/economics/therapy

KW - Hand Dermatoses/economics/therapy

KW - Hospitalization/economics

KW - Ultraviolet Therapy/economics

M3 - SCORING: Journal article

VL - 165

SP - 845

EP - 851

JO - BRIT J DERMATOL

JF - BRIT J DERMATOL

SN - 0007-0963

IS - 4

M1 - 4

ER -